Compounds > fingolimod hydrochloride
Page last updated: 2024-09-02

fingolimod hydrochloride and myelin oligodendrocyte glycoprotein (35-55)

fingolimod hydrochloride has been researched along with myelin oligodendrocyte glycoprotein (35-55) in 7 studies

Compound Research Comparison

Studies
(fingolimod hydrochloride)		Trials
(fingolimod hydrochloride)		Recent Studies (post-2010)
(fingolimod hydrochloride)		Studies
(myelin oligodendrocyte glycoprotein (35-55))		Trials
(myelin oligodendrocyte glycoprotein (35-55))		Recent Studies (post-2010) (myelin oligodendrocyte glycoprotein (35-55))
2,7711572,0627442458

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (14.29)29.6817
2010's6 (85.71)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chiba, K; Fukunari, A; Kataoka, H; Koyama, M; Shimano, K; Sugahara, K; Teshima, K1
Fujita, T; Kohno, T; Tsuji, T; Yoshida, Y1
Bernardi, G; Centonze, D; De Chiara, V; Furlan, R; Lo Giudice, T; Martino, G; Martorana, A; Motta, C; Musella, A; Rossi, S; Studer, V1
An, X; Goto, H; Kezuka, T; Matsuda, R; Matsunaga, Y; Usui, Y; Yamakawa, N1
Gil, C; Martín-Álvarez, R; Martínez, A; Mengod, G; Palomo, V; Paúl-Fernández, N1
Donahue, RR; Doolen, S; Grachen, CM; Iannitti, T; Shaw, BC; Taylor, BK1
Campos, MM; da Costa, JC; Gomez, MV; Greggio, S; Silva, RBM; Venturin, GT1

Other Studies

7 other study(ies) available for fingolimod hydrochloride and myelin oligodendrocyte glycoprotein (35-55)

ArticleYear
FTY720, sphingosine 1-phosphate receptor modulator, ameliorates experimental autoimmune encephalomyelitis by inhibition of T cell infiltration.
    Cellular & molecular immunology, 2005, Volume: 2, Issue:6

    Topics: Animals; Encephalomyelitis, Autoimmune, Experimental; Fingolimod Hydrochloride; Glycoproteins; Male; Mice; Myelin Basic Protein; Myelin Proteolipid Protein; Myelin-Oligodendrocyte Glycoprotein; Peptide Fragments; Propylene Glycols; Rats; Receptors, Lysosphingolipid; Sphingosine; T-Lymphocytes

2005
Relapse of experimental autoimmune encephalomyelitis after discontinuation of FTY720 (Fingolimod) treatment, but not after combination of FTY720 and pathogenic autoantigen.
    Biological & pharmaceutical bulletin, 2011, Volume: 34, Issue:6

    Topics: Animals; Autoantigens; Cyclosporine; Demyelinating Diseases; Drug Therapy, Combination; Encephalomyelitis, Autoimmune, Experimental; Female; Fingolimod Hydrochloride; Glycoproteins; Immunosuppression Therapy; Immunosuppressive Agents; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Myelin-Oligodendrocyte Glycoprotein; Nerve Tissue Proteins; Peptide Fragments; Propylene Glycols; Remission Induction; Secondary Prevention; Specific Pathogen-Free Organisms; Sphingosine; Spinal Cord

2011
Oral fingolimod rescues the functional deficits of synapses in experimental autoimmune encephalomyelitis.
    British journal of pharmacology, 2012, Volume: 165, Issue:4

    Topics: Animals; Dendritic Spines; Encephalomyelitis, Autoimmune, Experimental; Excitatory Postsynaptic Potentials; Female; Fingolimod Hydrochloride; Glutamic Acid; Glycoproteins; Immunosuppressive Agents; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Myelin-Oligodendrocyte Glycoprotein; Peptide Fragments; Propylene Glycols; Sphingosine; Synapses; Synaptic Transmission

2012
Suppression of experimental autoimmune optic neuritis by the novel agent fingolimod.
    Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society, 2013, Volume: 33, Issue:2

    Topics: Animals; Disease Models, Animal; Female; Fingolimod Hydrochloride; Freund's Adjuvant; Immunosuppressive Agents; Mice; Mice, Inbred C57BL; Myelin-Oligodendrocyte Glycoprotein; Neuritis, Autoimmune, Experimental; Optic Nerve; Peptide Fragments; Pertussis Toxin; Propylene Glycols; Sphingosine; Statistics, Nonparametric; Visual Acuity

2013
A preliminary investigation of phoshodiesterase 7 inhibitor VP3.15 as therapeutic agent for the treatment of experimental autoimmune encephalomyelitis mice.
    Journal of chemical neuroanatomy, 2017, Volume: 80

    Topics: Animals; Cell Proliferation; Cyclic Nucleotide Phosphodiesterases, Type 7; Encephalomyelitis, Autoimmune, Experimental; Enzyme Inhibitors; Female; Fingolimod Hydrochloride; Lymphocytes; Mice; Mice, Inbred C57BL; Myelin-Oligodendrocyte Glycoprotein; Peptide Fragments; Phosphodiesterase Inhibitors; Spinal Cord; Tumor Necrosis Factor-alpha

2017
Fingolimod reduces neuropathic pain behaviors in a mouse model of multiple sclerosis by a sphingosine-1 phosphate receptor 1-dependent inhibition of central sensitization in the dorsal horn.
    Pain, 2018, Volume: 159, Issue:2

    Topics: Anilides; Animals; Central Nervous System Sensitization; Disease Models, Animal; eIF-2 Kinase; Female; Fingolimod Hydrochloride; Immunosuppressive Agents; Male; Mice; Mice, Inbred C57BL; Motor Activity; Multiple Sclerosis; Myelin-Oligodendrocyte Glycoprotein; Neuralgia; Organophosphonates; Oxadiazoles; Pain Threshold; Peptide Fragments; Receptors, Lysosphingolipid; Sphingosine-1-Phosphate Receptors; Spinal Cord; Spinal Nerve Roots; Subcellular Fractions; Thiophenes

2018
Beneficial Effects of the Calcium Channel Blocker CTK 01512-2 in a Mouse Model of Multiple Sclerosis.
    Molecular neurobiology, 2018, Volume: 55, Issue:12

    Topics: Animals; Anti-Inflammatory Agents; Calcium Channel Blockers; Chemokines; Cognition Disorders; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Female; Fingolimod Hydrochloride; Hyperalgesia; Inflammation; Inflammation Mediators; Injections, Spinal; Mice, Inbred C57BL; Motor Activity; Multiple Sclerosis; Myelin Sheath; Myelin-Oligodendrocyte Glycoprotein; Nociception; omega-Conotoxins; Peptide Fragments

2018